2nd test

DMD Community Updates

Sarepta Therapeutics Announces FDA Will Not Complete the Review of the Eteplirsen New Drug Application By The PDUFA Date. Read more.

FDA Met to Discuss the Safety and Efficacy of Sarepta's Eteplirsen. Read more.